CN1935838A - 胸腺素β4衍生物及其应用 - Google Patents
胸腺素β4衍生物及其应用 Download PDFInfo
- Publication number
- CN1935838A CN1935838A CN 200510103293 CN200510103293A CN1935838A CN 1935838 A CN1935838 A CN 1935838A CN 200510103293 CN200510103293 CN 200510103293 CN 200510103293 A CN200510103293 A CN 200510103293A CN 1935838 A CN1935838 A CN 1935838A
- Authority
- CN
- China
- Prior art keywords
- gly
- lys
- glu
- rat
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (7)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101032937A CN100484957C (zh) | 2005-09-23 | 2005-09-23 | 胸腺素β4衍生物及其应用 |
EP06761426A EP1908779B1 (en) | 2005-07-15 | 2006-07-14 | Thymosin beta 4 derivatives and use thereof |
KR1020087003496A KR100984635B1 (ko) | 2005-07-15 | 2006-07-14 | 티모신 β4 유도체 및 이의 용도 |
JP2008520699A JP5180074B2 (ja) | 2005-07-15 | 2006-07-14 | サイモシンβ4誘導体及びその使用方法 |
PL06761426T PL1908779T3 (pl) | 2005-07-15 | 2006-07-14 | Pochodne tymozyny beta 4 i ich zastosowanie |
PCT/CN2006/001679 WO2007009359A1 (fr) | 2005-07-15 | 2006-07-14 | Derives de thymosine beta 4 et utilisation |
US11/995,817 US7816321B2 (en) | 2005-07-15 | 2006-07-14 | Thymosin β4 derivatives and use thereof |
CN200680025339A CN100582121C (zh) | 2005-07-15 | 2006-07-14 | 胸腺素β4衍生物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101032937A CN100484957C (zh) | 2005-09-23 | 2005-09-23 | 胸腺素β4衍生物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1935838A true CN1935838A (zh) | 2007-03-28 |
CN100484957C CN100484957C (zh) | 2009-05-06 |
Family
ID=37953602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101032937A Active CN100484957C (zh) | 2005-07-15 | 2005-09-23 | 胸腺素β4衍生物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100484957C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498788A (zh) * | 2018-06-26 | 2018-09-07 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4的用途 |
CN108853483A (zh) * | 2018-08-10 | 2018-11-23 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4在治疗脑缺血再灌注损伤方面的用途 |
CN110215513A (zh) * | 2018-11-15 | 2019-09-10 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4在治疗放射性肠炎方面的用途 |
CN110891591A (zh) * | 2017-06-14 | 2020-03-17 | 汇恩斯株式会社 | 用于治疗干眼症的包含甘氨酸-胸腺素β4(Gly-Tβ4)的药物组合物 |
CN111386337A (zh) * | 2017-11-24 | 2020-07-07 | Gtreebnt科技有限公司 | 包含胸腺素β4或其衍生物作为活性成分的用于促进杯状细胞增殖或粘蛋白分泌的组合物 |
CN112805298A (zh) * | 2018-08-07 | 2021-05-14 | 汇恩斯株式会社 | 制备GLY-Tβ4的方法 |
-
2005
- 2005-09-23 CN CNB2005101032937A patent/CN100484957C/zh active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110891591A (zh) * | 2017-06-14 | 2020-03-17 | 汇恩斯株式会社 | 用于治疗干眼症的包含甘氨酸-胸腺素β4(Gly-Tβ4)的药物组合物 |
EP3639842A4 (en) * | 2017-06-14 | 2021-03-24 | Huons Co., Ltd. | PHARMACEUTICAL COMPOSITION WITH GLY-THYMOSIN 4 (GLY-T 4) FOR THE TREATMENT OF DRY EYES |
CN111386337A (zh) * | 2017-11-24 | 2020-07-07 | Gtreebnt科技有限公司 | 包含胸腺素β4或其衍生物作为活性成分的用于促进杯状细胞增殖或粘蛋白分泌的组合物 |
CN108498788A (zh) * | 2018-06-26 | 2018-09-07 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4的用途 |
CN112805298A (zh) * | 2018-08-07 | 2021-05-14 | 汇恩斯株式会社 | 制备GLY-Tβ4的方法 |
CN108853483A (zh) * | 2018-08-10 | 2018-11-23 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4在治疗脑缺血再灌注损伤方面的用途 |
CN108853483B (zh) * | 2018-08-10 | 2022-03-15 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4在治疗脑缺血再灌注损伤方面的用途 |
CN110215513A (zh) * | 2018-11-15 | 2019-09-10 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4在治疗放射性肠炎方面的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN100484957C (zh) | 2009-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100582121C (zh) | 胸腺素β4衍生物及其应用 | |
CN100484957C (zh) | 胸腺素β4衍生物及其应用 | |
CN102883736B (zh) | 用于促进血管生成的肽及其用途 | |
US20110117195A1 (en) | Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers | |
CN1978466B (zh) | 转导肽-人脑源性神经营养因子融合蛋白及其应用 | |
CN102884073B (zh) | 用于促进血管生成的肽及其用途 | |
CN1896096A (zh) | 基因工程方法生产的高活性胸腺素β4衍生物 | |
CN100372572C (zh) | 携带人胸腺素β4基因的重组质粒 | |
CN100535005C (zh) | 长链人胰岛素样生长因子(lr3igf-1)及其制备和应用方法 | |
CN117510619B (zh) | 一种创新空间结构的重组ⅲ型人源化胶原蛋白微球及其设计、制备工艺和应用 | |
CN102397534B (zh) | 胰岛素在制备促进颌骨组织愈合的药物中的用途 | |
CN101899116B (zh) | 无创性高穿透性表皮生长因子及其应用 | |
CN103031268B (zh) | OGP-rhLeptin融合蛋白转基因工程菌株 | |
CN101921820A (zh) | 具有活性重组肿瘤特异性凋亡因子的制备方法及其制品的应用 | |
CN102964451B (zh) | 用于治疗骨质疏松症和止痛的msCT-CTx融合蛋白及编码该融合蛋白的核酸 | |
CN102964452B (zh) | 用于治骨质疏松症和肥胖的msCT-rhLeptin融合蛋白及编码该融合蛋白的核酸 | |
CN103012597B (zh) | 用于治疗骨质疏松症和止痛的OGP-CTx融合蛋白及编码该融合蛋白的核酸 | |
CN102965325B (zh) | msCT-CTx融合蛋白转基因工程菌株 | |
CN103013901B (zh) | OGP-CTx融合蛋白转基因工程菌株 | |
CN101306193A (zh) | 人神经突起生长素在制备创伤愈合药物中的应用 | |
CN102675449B (zh) | 缺失型人角质细胞生长因子-ⅰ二硫键变构体及其用途 | |
JP2003113095A (ja) | Dna合成促進剤 | |
CN101787081A (zh) | 胸腺素α1-胸腺生成素-2基因工程融合蛋白 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Thymosin beta4 derivative and itsuse Effective date of registration: 20100415 Granted publication date: 20090506 Pledgee: Zhongguancun Beijing science and technology Company limited by guarantee Pledgor: Beijing Northland Biotechnology Co., Ltd. Registration number: 2010990000737 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20110419 Granted publication date: 20090506 Pledgee: Zhongguancun Beijing science and technology Company limited by guarantee Pledgor: Beijing Northland Biotechnology Co., Ltd. Registration number: 2010990000737 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070328 Assignee: Beijing North Rand Medical Technology Co., Ltd. Assignor: Beijing Northland Biotechnology Co., Ltd. Contract record no.: 2012990000805 Denomination of invention: Thymosin beta4 derivative and itsuse Granted publication date: 20090506 License type: Exclusive License Record date: 20121031 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |